Results 191 to 200 of about 8,038,703 (314)

A distributed software system for integrating data-intensive imaging methods in a hard X-ray nanoprobe beamline at the SSRF. [PDF]

J Synchrotron Radiat
Zhang P, Jiang Z, He Y, Li A.
europepmc   +1 more source

Encapsulating HPC System Level Complexities via Software Framework

, 2015
Saurav Das
openalex   +2 more sources

SOFTWARE FOR INFORMATION SYSTEMS IN BANKS

, 2022
Ishonqulova Nargiza Mamajonovna
openalex   +1 more source

CATALOGING DEPENDENCY INJECTION ANTI-PATTERNS IN SOFTWARE SYSTEMS [PDF]

, 2020
Rodrigo Laigner
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Designing and modeling an IoT-based software system for land suitability assessment use case. [PDF]

Environ Monit Assess
Mohammad El-Basioni BM, Abd El-Kader SM.
europepmc   +1 more source

Software demonstration: the TshwaneLex electronic dictionary system [PDF]

, 2008
de Schryver, Gilles-Maurice, Joffe, D, MacLeod, M   +2 more
core  

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

TEST CASE GENERATION FOR EMBEDDED SYSTEM SOFTWARE USING UML INTERACTION DIAGRAM

, 2017
P Mani, M. Prasanna
openalex   +1 more source